Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). Academic Article uri icon

Overview

abstract

  • Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.

publication date

  • October 15, 2004

Research

keywords

  • Aortic Valve
  • Atenolol
  • Heart Valve Diseases
  • Losartan

Identity

Scopus Document Identifier

  • 5044238644

Digital Object Identifier (DOI)

  • 10.1016/j.amjcard.2004.06.074

PubMed ID

  • 15476632

Additional Document Info

volume

  • 94

issue

  • 8